CCM
Catapult Capital Management Portfolio holdings
AUM
$193M
This Quarter Return
-5.11%
1 Year Return
+19.4%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$193M
AUM Growth
+$193M
(-66%)
Cap. Flow
-$347M
Cap. Flow
% of AUM
-179.52%
Top 10 Holdings %
Top 10 Hldgs %
35.59%
Holding
263
New
42
Increased
15
Reduced
59
Closed
100
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$8.83M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
$4.1M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$3.12M |
| 4 |
Boston Scientific
BSX
|
$3.04M |
| 5 |
BCR
CR Bard Inc.
BCR
|
$2.9M |
Top Sells
| 1 |
CVS Health
CVS
|
$14.6M |
| 2 |
AbbVie
ABBV
|
$13.3M |
| 3 |
PepsiCo
PEP
|
$12.8M |
| 4 |
McKesson
MCK
|
$12.4M |
| 5 |
Zoetis
ZTS
|
$12M |
Sector Composition
| 1 | Healthcare | 56.56% |
| 2 | Consumer Discretionary | 10.06% |
| 3 | Industrials | 8.88% |
| 4 | Technology | 5.6% |
| 5 | Financials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $11.6M | 4.37% | 42,500 +32,500 | +325% | +$8.83M |
|
2
Edwards Lifesciences
EW
$47.8B
| $9.03M | 3.42% | 63,543 -57,410 | -47% | -$8.16M |
|
|
3
Zoetis
ZTS
$69.3B
| $8.05M | 3.04% | 195,525 -291,140 | -60% | -$12M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $7.97M | 3.01% | 72,877 +22,877 | +46% | +$2.5M |
|
|
NUVA
5
DELISTED
NuVasive, Inc.
NUVA
| $6.51M | 2.46% | 135,000 +85,000 | +170% | +$4.1M |
|
6
DaVita
DVA
$9.85B
| $6.14M | 2.32% | 84,938 -90,162 | -51% | -$6.52M |
|
|
7
Boston Scientific
BSX
$156B
| $5.5M | 2.08% | 335,000 +185,000 | +123% | +$3.04M |
|
8
AtriCure
ATRC
$1.84B
| $4.93M | 1.86% | 225,000 +15,000 | +7% | +$329K |
|
9
Universal Health Services
UHS
$11.6B
| $4.76M | 1.8% | 38,095 -51,905 | -58% | -$6.48M |
|
|
ALR
10
DELISTED
Alere Inc
ALR
| $4.41M | 1.67% | 91,622 +41,622 | +83% | +$2M |
|
|
11
CVS Health
CVS
$92.8B
| $4.36M | 1.65% | 45,172 -151,775 | -77% | -$14.6M |
|
12
Cross Country Healthcare
CCRN
$438M
| $3.74M | 1.41% | 275,000 +25,000 | +10% | +$340K |
|
13
Gilead Sciences
GILD
$140B
| $3.58M | 1.35% | 36,408 -34,392 | -49% | -$3.38M |
|
14
Align Technology
ALGN
$10.3B
| $3.39M | 1.28% | 59,722 -20,278 | -25% | -$1.15M |
|
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $3.12M | 1.18% | +30,000 | New | +$3.12M |
|
16
McDonald's
MCD
$224B
| $3.06M | 1.15% | 31,007 -35,193 | -53% | -$3.47M |
|
|
BCR
17
DELISTED
CR Bard Inc.
BCR
| $2.9M | 1.09% | +15,537 | New | +$2.9M |
|
18
Pfizer
PFE
$141B
| $2.82M | 1.07% | +89,807 | New | +$2.82M |
|
|
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.53M | 0.96% | 27,500 +2,500 | +10% | +$230K |
|
20
Meta Platforms (Facebook)
META
$1.86T
| $2.5M | 0.95% | 27,809 -52,071 | -65% | -$4.68M |
|
|
RDUS
21
DELISTED
Radius Health, Inc.
RDUS
| $2.5M | 0.94% | 36,000 +11,000 | +44% | +$762K |
|
|
SHPG
22
DELISTED
Shire pic
SHPG
| $2.42M | 0.91% | 11,787 -51,468 | -81% | -$10.6M |
|
23
Pediatrix Medical
MD
$1.5B
| $2.22M | 0.84% | 28,926 +9,712 | +51% | +$746K |
|
24
Stanley Black & Decker
SWK
$11.5B
| $2.2M | 0.83% | 22,699 -1,500 | -6% | -$145K |
|
25
Molson Coors Class B
TAP
$9.98B
| $1.88M | 0.71% | 22,614 -52,670 | -70% | -$4.37M |
|